Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Professional Medical Expertise CoSAU:9574 42 Return-on-Tangible-Equity is 27.80% as of Dec. 2025, which is 0% above its 10-year median of 27.72. GuruFocus rates SAU:9574 with a GF Score™ of 42/100 and a GF Value™ of ﷼148.48 (Significantly Undervalued). The stock has 2 warning signs investors should review. Among 759 Medical Devices & Instruments companies, Professional Medical Expertise Co ranks better than 89.06% on this metric.
The historical rank and industry rank for Professional Medical Expertise Co's Return-on-Tangible-Equity or its related term are showing as below:
SAU:9574'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: 25.98 Med: 27.72 Max: 31.67
Current: 31.66
During the past 4 years, Professional Medical Expertise Co's highest Return-on-Tangible-Equity was 31.67%. The lowest was 25.98%. And the median was 27.72%.
SAU:9574's Return-on-Tangible-Equity is ranked better than 89.06% of 759
companies
in the Medical Devices & Instruments industry
Industry Median: 4.02
vs SAU:9574: 31.66
Professional Medical Expertise Co (SAU:9574) Return-on-Tangible-Equity Explanation
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
Professional Medical Expertise Co Return-on-Tangible-Equity Related Terms
Professional Medical Expertise Co Return-on-Tangible-Equity Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Professional Medical Expertise Co Return-on-Tangible-Equity Chart
Professional Medical Expertise Co Annual Data
Trend
Dec22
Dec23
Dec24
Dec25
Return-on-Tangible-Equity
25.98
29.16
26.28
31.67
Professional Medical Expertise Co Semi-Annual Data
SAU:9574 vs ABT, SYK, MDT: Return-on-Tangible-Equity Comparison
For the Medical Devices subindustry, Professional Medical Expertise Co's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Professional Medical Expertise Co Return-on-Tangible-Equity vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Professional Medical Expertise Co's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where Professional Medical Expertise Co's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is two times the semi-annual (Dec. 2025) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of 27.80% mean?
Professional Medical Expertise Co (SAU:9574) has a Return-on-Tangible-Equity of 27.80% as of Dec. 2025. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Professional Medical Expertise Co and its competitors. This is near median its historical median of 27.72. Over the past decade, Professional Medical Expertise Co's Return-on-Tangible-Equity has ranged from 25.98 to 31.67. According to the industry distribution chart, Professional Medical Expertise Co ranks #83 out of 759 companies in the Medical Devices & Instruments industry, placing it in the top 10.9%.
Is Professional Medical Expertise Co's Return-on-Tangible-Equity too high?
Professional Medical Expertise Co's current Return-on-Tangible-Equity of 27.80% is near median its 10-year median of 27.72. Over the past 10 years, this metric has ranged from a low of 25.98 to a high of 31.67. The Medical Devices & Instruments industry median Return-on-Tangible-Equity is 4.02. Professional Medical Expertise Co's value of 27.80% is 591.5% above this industry median. Based on the distribution chart, Professional Medical Expertise Co ranks #83 out of 759 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Professional Medical Expertise Co has a GF Score™ of 42/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Professional Medical Expertise Co's Return-on-Tangible-Equity compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Professional Medical Expertise Co ranks #83 out of 759 companies for Return-on-Tangible-Equity. This places Professional Medical Expertise Co in the top 11% of its industry — outperforming the majority of peers. The industry median Return-on-Tangible-Equity is 4.02. Professional Medical Expertise Co's value of 27.80% is 591.5% above this benchmark. Historically, Professional Medical Expertise Co's own Return-on-Tangible-Equity has ranged from 25.98 to 31.67 over the past decade. While the company's 10-year median is 27.72 vs. the industry median of 4.02, Professional Medical Expertise Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Medical Devices & Instruments company?
The median Return-on-Tangible-Equity among Medical Devices & Instruments companies is 4.02, based on 759 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Professional Medical Expertise Co's current Return-on-Tangible-Equity of 27.80% is 591.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Professional Medical Expertise Co and its competitors. For the Medical Devices & Instruments industry, the median Return-on-Tangible-Equity is 4.02 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Professional Medical Expertise Co's current Return-on-Tangible-Equity is 27.80%, which is near median its own 10-year median of 27.72. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Professional Medical Expertise Co stock overvalued right now?
Based on GuruFocus' analysis, Professional Medical Expertise Co (SAU:9574) is currently considered Significantly Undervalued. The stock's GF Value™ is ﷼148.48, compared to a current price of ﷼83.00 — trading 44.1% below its estimated fair value. The current Return-on-Tangible-Equity is 27.80%, which is near median its 10-year median of 27.72 and 591.5% above the Medical Devices & Instruments industry median of 4.02. Professional Medical Expertise Co's overall GF Score™ is 42/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For Professional Medical Expertise Co (SAU:9574), the current Return-on-Tangible-Equity is 27.80% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Professional Medical Expertise Co (SAU:9574) Overvalued in 2026?
Based on GuruFocus' analysis, Professional Medical Expertise Co stock appears to be undervalued.
The current stock price of ﷼83.00 is trading 44.1% below its estimated GF Value™ of ﷼148.48.
GuruFocus considers Professional Medical Expertise Co to be Significantly Undervalued.
Key valuation signals for SAU:9574:
Return-on-Tangible-Equity: 27.80% (near median its 10-year median of 27.72)
GF Value™: ﷼148.48 vs. price of ﷼83.00 (44.1% below fair value)
Industry Position: 591.5% above the Medical Devices & Instruments median (#83 of 759)
No single metric tells the full story. See the SAU:9574 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Professional Medical Expertise Co is engaged in the distribution of medical devices and related products, including the import, export, and sale of medical implants, devices, and consumables to hospitals and medical centers. Its activities include acting as sales agents for pharmaceuticals, retail sale of medical equipment and supplies, warehousing and storage of medical and pharmaceutical products, and legal representation of medical device manufacturers.
42GF Score
Get the complete analysis for SAU:9574
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SAU:9574 has been successfully added to your 
